nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ALB—melanoma	0.151	0.512	CbGaD
Losartan—ABCB1—melanoma	0.144	0.488	CbGaD
Losartan—SLCO1B3—Docetaxel—melanoma	0.0769	0.189	CbGbCtD
Losartan—ALB—Vemurafenib—melanoma	0.0715	0.176	CbGbCtD
Losartan—CYP1A2—Carmustine—melanoma	0.0541	0.133	CbGbCtD
Losartan—CYP1A2—Vemurafenib—melanoma	0.0427	0.105	CbGbCtD
Losartan—CYP3A4—Temozolomide—melanoma	0.0409	0.101	CbGbCtD
Losartan—CYP1A2—Dacarbazine—melanoma	0.0328	0.0806	CbGbCtD
Losartan—ABCB1—Dactinomycin—melanoma	0.0248	0.0611	CbGbCtD
Losartan—CYP3A4—Vemurafenib—melanoma	0.0224	0.0551	CbGbCtD
Losartan—CYP3A5—Docetaxel—melanoma	0.0197	0.0485	CbGbCtD
Losartan—ABCB1—Docetaxel—melanoma	0.0128	0.0316	CbGbCtD
Losartan—CYP3A4—Docetaxel—melanoma	0.00768	0.0189	CbGbCtD
Losartan—SLC2A9—hair follicle—melanoma	0.00369	0.167	CbGeAlD
Losartan—ACE—umbilical vein—melanoma	0.00224	0.101	CbGeAlD
Losartan—ACE—hindlimb—melanoma	0.00205	0.0929	CbGeAlD
Losartan—ACE—arm—melanoma	0.00196	0.0887	CbGeAlD
Losartan—ACE—appendage—melanoma	0.00176	0.0797	CbGeAlD
Losartan—AGTR1—endothelium—melanoma	0.00144	0.0652	CbGeAlD
Losartan—AGTR1—blood vessel—melanoma	0.00133	0.0601	CbGeAlD
Losartan—ACE—endothelium—melanoma	0.00106	0.0481	CbGeAlD
Losartan—ACE—blood vessel—melanoma	0.00098	0.0444	CbGeAlD
Losartan—AGTR1—neck—melanoma	0.000949	0.043	CbGeAlD
Losartan—Telmisartan—PPARG—melanoma	0.000925	0.488	CrCbGaD
Losartan—SLC2A9—lymph node—melanoma	0.000732	0.0332	CbGeAlD
Losartan—ACE—neck—melanoma	0.000701	0.0317	CbGeAlD
Losartan—ACE—eye—melanoma	0.000521	0.0236	CbGeAlD
Losartan—ACE—mammalian vulva—melanoma	0.000414	0.0187	CbGeAlD
Losartan—AGTR1—head—melanoma	0.000401	0.0182	CbGeAlD
Losartan—Erythema multiforme—Dactinomycin—melanoma	0.000396	0.00298	CcSEcCtD
Losartan—Sinusitis—Temozolomide—melanoma	0.000396	0.00297	CcSEcCtD
Losartan—Erythema—Bleomycin—melanoma	0.000391	0.00294	CcSEcCtD
Losartan—Hypoaesthesia—Carmustine—melanoma	0.00039	0.00293	CcSEcCtD
Losartan—Flushing—Dactinomycin—melanoma	0.000389	0.00292	CcSEcCtD
Losartan—Hypersensitivity—Vemurafenib—melanoma	0.000388	0.00292	CcSEcCtD
Losartan—Atrial fibrillation—Docetaxel—melanoma	0.000384	0.00289	CcSEcCtD
Losartan—Renal impairment—Docetaxel—melanoma	0.000383	0.00287	CcSEcCtD
Losartan—Hepatitis—Temozolomide—melanoma	0.000379	0.00285	CcSEcCtD
Losartan—Asthenia—Vemurafenib—melanoma	0.000378	0.00284	CcSEcCtD
Losartan—Hypoaesthesia—Temozolomide—melanoma	0.000377	0.00283	CcSEcCtD
Losartan—Pharyngitis—Temozolomide—melanoma	0.000376	0.00282	CcSEcCtD
Losartan—Pruritus—Vemurafenib—melanoma	0.000373	0.0028	CcSEcCtD
Losartan—Alopecia—Dactinomycin—melanoma	0.00037	0.00278	CcSEcCtD
Losartan—Valsartan—ALB—melanoma	0.00037	0.195	CrCbGaD
Losartan—Hyponatraemia—Docetaxel—melanoma	0.000366	0.00275	CcSEcCtD
Losartan—Erythema—Dactinomycin—melanoma	0.000365	0.00274	CcSEcCtD
Losartan—Pain in extremity—Docetaxel—melanoma	0.000364	0.00274	CcSEcCtD
Losartan—Flushing—Carmustine—melanoma	0.000364	0.00273	CcSEcCtD
Losartan—Ill-defined disorder—Bleomycin—melanoma	0.000363	0.00273	CcSEcCtD
Losartan—Anaemia—Bleomycin—melanoma	0.000361	0.00271	CcSEcCtD
Losartan—Diarrhoea—Vemurafenib—melanoma	0.00036	0.00271	CcSEcCtD
Losartan—Migraine—Docetaxel—melanoma	0.000358	0.00269	CcSEcCtD
Losartan—Erythema multiforme—Temozolomide—melanoma	0.000358	0.00269	CcSEcCtD
Losartan—Tinnitus—Temozolomide—melanoma	0.000353	0.00265	CcSEcCtD
Losartan—Malaise—Bleomycin—melanoma	0.000353	0.00265	CcSEcCtD
Losartan—Flushing—Temozolomide—melanoma	0.000352	0.00264	CcSEcCtD
Losartan—Arrhythmia—Carmustine—melanoma	0.00035	0.00263	CcSEcCtD
Losartan—Leukopenia—Bleomycin—melanoma	0.00035	0.00263	CcSEcCtD
Losartan—Dizziness—Vemurafenib—melanoma	0.000348	0.00262	CcSEcCtD
Losartan—Alopecia—Carmustine—melanoma	0.000346	0.0026	CcSEcCtD
Losartan—ABCB1—blood vessel—melanoma	0.000345	0.0156	CbGeAlD
Losartan—Angiopathy—Temozolomide—melanoma	0.000344	0.00258	CcSEcCtD
Losartan—Ataxia—Docetaxel—melanoma	0.000342	0.00257	CcSEcCtD
Losartan—Erythema—Carmustine—melanoma	0.000341	0.00256	CcSEcCtD
Losartan—Cough—Bleomycin—melanoma	0.000341	0.00256	CcSEcCtD
Losartan—Ill-defined disorder—Dactinomycin—melanoma	0.000338	0.00254	CcSEcCtD
Losartan—Anaemia—Dactinomycin—melanoma	0.000337	0.00253	CcSEcCtD
Losartan—Vomiting—Vemurafenib—melanoma	0.000335	0.00252	CcSEcCtD
Losartan—Alopecia—Temozolomide—melanoma	0.000335	0.00252	CcSEcCtD
Losartan—Dry skin—Docetaxel—melanoma	0.000334	0.00251	CcSEcCtD
Losartan—Chest pain—Bleomycin—melanoma	0.000333	0.0025	CcSEcCtD
Losartan—Myalgia—Bleomycin—melanoma	0.000333	0.0025	CcSEcCtD
Losartan—Orthostatic hypotension—Docetaxel—melanoma	0.000333	0.0025	CcSEcCtD
Losartan—Rash—Vemurafenib—melanoma	0.000332	0.00249	CcSEcCtD
Losartan—Telmisartan—ABCB1—melanoma	0.000332	0.175	CrCbGaD
Losartan—Dermatitis—Vemurafenib—melanoma	0.000332	0.00249	CcSEcCtD
Losartan—Back pain—Carmustine—melanoma	0.00033	0.00248	CcSEcCtD
Losartan—Headache—Vemurafenib—melanoma	0.00033	0.00248	CcSEcCtD
Losartan—Erythema—Temozolomide—melanoma	0.00033	0.00248	CcSEcCtD
Losartan—Breast disorder—Docetaxel—melanoma	0.000329	0.00247	CcSEcCtD
Losartan—Discomfort—Bleomycin—melanoma	0.000329	0.00247	CcSEcCtD
Losartan—Malaise—Dactinomycin—melanoma	0.000329	0.00247	CcSEcCtD
Losartan—Cramp muscle—Docetaxel—melanoma	0.000328	0.00246	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000328	0.00246	CcSEcCtD
Losartan—Leukopenia—Dactinomycin—melanoma	0.000326	0.00245	CcSEcCtD
Losartan—Dysgeusia—Temozolomide—melanoma	0.000323	0.00243	CcSEcCtD
Losartan—Confusional state—Bleomycin—melanoma	0.000322	0.00242	CcSEcCtD
Losartan—Vision blurred—Carmustine—melanoma	0.000322	0.00242	CcSEcCtD
Losartan—Tremor—Carmustine—melanoma	0.00032	0.0024	CcSEcCtD
Losartan—Anaphylactic shock—Bleomycin—melanoma	0.000319	0.0024	CcSEcCtD
Losartan—Oedema—Bleomycin—melanoma	0.000319	0.0024	CcSEcCtD
Losartan—Back pain—Temozolomide—melanoma	0.000319	0.0024	CcSEcCtD
Losartan—Infection—Bleomycin—melanoma	0.000317	0.00238	CcSEcCtD
Losartan—Anaemia—Carmustine—melanoma	0.000315	0.00237	CcSEcCtD
Losartan—Agitation—Carmustine—melanoma	0.000314	0.00236	CcSEcCtD
Losartan—Nausea—Vemurafenib—melanoma	0.000313	0.00235	CcSEcCtD
Losartan—Thrombocytopenia—Bleomycin—melanoma	0.000312	0.00235	CcSEcCtD
Losartan—Vision blurred—Temozolomide—melanoma	0.000311	0.00233	CcSEcCtD
Losartan—Myalgia—Dactinomycin—melanoma	0.00031	0.00233	CcSEcCtD
Losartan—Tremor—Temozolomide—melanoma	0.000309	0.00232	CcSEcCtD
Losartan—Discomfort—Dactinomycin—melanoma	0.000307	0.0023	CcSEcCtD
Losartan—Angina pectoris—Docetaxel—melanoma	0.000307	0.0023	CcSEcCtD
Losartan—Ill-defined disorder—Temozolomide—melanoma	0.000306	0.0023	CcSEcCtD
Losartan—Leukopenia—Carmustine—melanoma	0.000306	0.00229	CcSEcCtD
Losartan—Anaemia—Temozolomide—melanoma	0.000305	0.00229	CcSEcCtD
Losartan—Anorexia—Bleomycin—melanoma	0.000304	0.00228	CcSEcCtD
Losartan—Agitation—Temozolomide—melanoma	0.000303	0.00228	CcSEcCtD
Losartan—Angioedema—Temozolomide—melanoma	0.000301	0.00226	CcSEcCtD
Losartan—Hypotension—Bleomycin—melanoma	0.000298	0.00224	CcSEcCtD
Losartan—Oedema—Dactinomycin—melanoma	0.000298	0.00224	CcSEcCtD
Losartan—Malaise—Temozolomide—melanoma	0.000297	0.00223	CcSEcCtD
Losartan—Vertigo—Temozolomide—melanoma	0.000296	0.00223	CcSEcCtD
Losartan—ACE—head—melanoma	0.000296	0.0134	CbGeAlD
Losartan—Infection—Dactinomycin—melanoma	0.000296	0.00222	CcSEcCtD
Losartan—Leukopenia—Temozolomide—melanoma	0.000295	0.00222	CcSEcCtD
Losartan—Palpitations—Temozolomide—melanoma	0.000291	0.00219	CcSEcCtD
Losartan—Thrombocytopenia—Dactinomycin—melanoma	0.000291	0.00219	CcSEcCtD
Losartan—Musculoskeletal discomfort—Bleomycin—melanoma	0.000291	0.00218	CcSEcCtD
Losartan—Myalgia—Carmustine—melanoma	0.000291	0.00218	CcSEcCtD
Losartan—Chest pain—Carmustine—melanoma	0.000291	0.00218	CcSEcCtD
Losartan—Anxiety—Carmustine—melanoma	0.00029	0.00218	CcSEcCtD
Losartan—Cough—Temozolomide—melanoma	0.000288	0.00216	CcSEcCtD
Losartan—Paraesthesia—Bleomycin—melanoma	0.000287	0.00215	CcSEcCtD
Losartan—Weight increased—Docetaxel—melanoma	0.000286	0.00215	CcSEcCtD
Losartan—Dyspnoea—Bleomycin—melanoma	0.000284	0.00214	CcSEcCtD
Losartan—Anorexia—Dactinomycin—melanoma	0.000284	0.00213	CcSEcCtD
Losartan—Pneumonia—Docetaxel—melanoma	0.000282	0.00212	CcSEcCtD
Losartan—Confusional state—Carmustine—melanoma	0.000281	0.00211	CcSEcCtD
Losartan—Arthralgia—Temozolomide—melanoma	0.000281	0.00211	CcSEcCtD
Losartan—Myalgia—Temozolomide—melanoma	0.000281	0.00211	CcSEcCtD
Losartan—AGTR1—lymph node—melanoma	0.000281	0.0127	CbGeAlD
Losartan—Anxiety—Temozolomide—melanoma	0.00028	0.0021	CcSEcCtD
Losartan—Oedema—Carmustine—melanoma	0.000279	0.00209	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000278	0.00209	CcSEcCtD
Losartan—Discomfort—Temozolomide—melanoma	0.000277	0.00208	CcSEcCtD
Losartan—Decreased appetite—Bleomycin—melanoma	0.000277	0.00208	CcSEcCtD
Losartan—Infection—Carmustine—melanoma	0.000277	0.00208	CcSEcCtD
Losartan—Renal failure—Docetaxel—melanoma	0.000276	0.00207	CcSEcCtD
Losartan—Neuropathy peripheral—Docetaxel—melanoma	0.000275	0.00207	CcSEcCtD
Losartan—Dry mouth—Temozolomide—melanoma	0.000275	0.00206	CcSEcCtD
Losartan—Jaundice—Docetaxel—melanoma	0.000274	0.00206	CcSEcCtD
Losartan—Pain—Bleomycin—melanoma	0.000273	0.00205	CcSEcCtD
Losartan—Conjunctivitis—Docetaxel—melanoma	0.000273	0.00205	CcSEcCtD
Losartan—Thrombocytopenia—Carmustine—melanoma	0.000273	0.00205	CcSEcCtD
Losartan—Tachycardia—Carmustine—melanoma	0.000272	0.00204	CcSEcCtD
Losartan—Confusional state—Temozolomide—melanoma	0.000271	0.00204	CcSEcCtD
Losartan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000271	0.00204	CcSEcCtD
Losartan—Anaphylactic shock—Temozolomide—melanoma	0.000269	0.00202	CcSEcCtD
Losartan—Oedema—Temozolomide—melanoma	0.000269	0.00202	CcSEcCtD
Losartan—Candesartan—ABCB1—melanoma	0.000268	0.141	CrCbGaD
Losartan—Infection—Temozolomide—melanoma	0.000267	0.00201	CcSEcCtD
Losartan—Anorexia—Carmustine—melanoma	0.000266	0.00199	CcSEcCtD
Losartan—Epistaxis—Docetaxel—melanoma	0.000265	0.00199	CcSEcCtD
Losartan—Nervous system disorder—Temozolomide—melanoma	0.000264	0.00198	CcSEcCtD
Losartan—Thrombocytopenia—Temozolomide—melanoma	0.000264	0.00198	CcSEcCtD
Losartan—Feeling abnormal—Bleomycin—melanoma	0.000263	0.00198	CcSEcCtD
Losartan—Agranulocytosis—Docetaxel—melanoma	0.000262	0.00197	CcSEcCtD
Losartan—Hypotension—Carmustine—melanoma	0.00026	0.00196	CcSEcCtD
Losartan—Hyperhidrosis—Temozolomide—melanoma	0.00026	0.00195	CcSEcCtD
Losartan—Decreased appetite—Dactinomycin—melanoma	0.000259	0.00194	CcSEcCtD
Losartan—Fatigue—Dactinomycin—melanoma	0.000257	0.00193	CcSEcCtD
Losartan—Anorexia—Temozolomide—melanoma	0.000257	0.00193	CcSEcCtD
Losartan—Pain—Dactinomycin—melanoma	0.000255	0.00191	CcSEcCtD
Losartan—Musculoskeletal discomfort—Carmustine—melanoma	0.000254	0.00191	CcSEcCtD
Losartan—Urticaria—Bleomycin—melanoma	0.000254	0.0019	CcSEcCtD
Losartan—Rhinitis—Docetaxel—melanoma	0.000253	0.0019	CcSEcCtD
Losartan—Body temperature increased—Bleomycin—melanoma	0.000252	0.00189	CcSEcCtD
Losartan—Hepatitis—Docetaxel—melanoma	0.000252	0.00189	CcSEcCtD
Losartan—Insomnia—Carmustine—melanoma	0.000252	0.00189	CcSEcCtD
Losartan—Hypoaesthesia—Docetaxel—melanoma	0.000251	0.00188	CcSEcCtD
Losartan—Paraesthesia—Carmustine—melanoma	0.00025	0.00188	CcSEcCtD
Losartan—Pharyngitis—Docetaxel—melanoma	0.00025	0.00188	CcSEcCtD
Losartan—Dyspnoea—Carmustine—melanoma	0.000248	0.00187	CcSEcCtD
Losartan—Somnolence—Carmustine—melanoma	0.000248	0.00186	CcSEcCtD
Losartan—Feeling abnormal—Dactinomycin—melanoma	0.000245	0.00184	CcSEcCtD
Losartan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000245	0.00184	CcSEcCtD
Losartan—Insomnia—Temozolomide—melanoma	0.000243	0.00183	CcSEcCtD
Losartan—Gastrointestinal pain—Dactinomycin—melanoma	0.000243	0.00183	CcSEcCtD
Losartan—Decreased appetite—Carmustine—melanoma	0.000242	0.00182	CcSEcCtD
Losartan—Paraesthesia—Temozolomide—melanoma	0.000242	0.00182	CcSEcCtD
Losartan—Dyspnoea—Temozolomide—melanoma	0.00024	0.0018	CcSEcCtD
Losartan—Somnolence—Temozolomide—melanoma	0.000239	0.0018	CcSEcCtD
Losartan—Erythema multiforme—Docetaxel—melanoma	0.000238	0.00179	CcSEcCtD
Losartan—Constipation—Carmustine—melanoma	0.000238	0.00179	CcSEcCtD
Losartan—Pain—Carmustine—melanoma	0.000238	0.00179	CcSEcCtD
Losartan—Dyspepsia—Temozolomide—melanoma	0.000237	0.00178	CcSEcCtD
Losartan—Body temperature increased—Dactinomycin—melanoma	0.000235	0.00177	CcSEcCtD
Losartan—Abdominal pain—Dactinomycin—melanoma	0.000235	0.00177	CcSEcCtD
Losartan—Hypersensitivity—Bleomycin—melanoma	0.000235	0.00177	CcSEcCtD
Losartan—Decreased appetite—Temozolomide—melanoma	0.000234	0.00176	CcSEcCtD
Losartan—Flushing—Docetaxel—melanoma	0.000234	0.00176	CcSEcCtD
Losartan—Fatigue—Temozolomide—melanoma	0.000232	0.00174	CcSEcCtD
Losartan—Pain—Temozolomide—melanoma	0.00023	0.00173	CcSEcCtD
Losartan—Constipation—Temozolomide—melanoma	0.00023	0.00173	CcSEcCtD
Losartan—Feeling abnormal—Carmustine—melanoma	0.00023	0.00172	CcSEcCtD
Losartan—Asthenia—Bleomycin—melanoma	0.000229	0.00172	CcSEcCtD
Losartan—Angiopathy—Docetaxel—melanoma	0.000229	0.00172	CcSEcCtD
Losartan—Gastrointestinal pain—Carmustine—melanoma	0.000228	0.00171	CcSEcCtD
Losartan—Pruritus—Bleomycin—melanoma	0.000226	0.0017	CcSEcCtD
Losartan—Arrhythmia—Docetaxel—melanoma	0.000225	0.00169	CcSEcCtD
Losartan—Alopecia—Docetaxel—melanoma	0.000223	0.00167	CcSEcCtD
Losartan—Feeling abnormal—Temozolomide—melanoma	0.000222	0.00167	CcSEcCtD
Losartan—Abdominal pain—Carmustine—melanoma	0.00022	0.00165	CcSEcCtD
Losartan—Body temperature increased—Carmustine—melanoma	0.00022	0.00165	CcSEcCtD
Losartan—Gastrointestinal pain—Temozolomide—melanoma	0.00022	0.00165	CcSEcCtD
Losartan—Erythema—Docetaxel—melanoma	0.000219	0.00165	CcSEcCtD
Losartan—Hypersensitivity—Dactinomycin—melanoma	0.000219	0.00165	CcSEcCtD
Losartan—ALB—lymph node—melanoma	0.000217	0.0098	CbGeAlD
Losartan—Dysgeusia—Docetaxel—melanoma	0.000215	0.00161	CcSEcCtD
Losartan—Urticaria—Temozolomide—melanoma	0.000214	0.00161	CcSEcCtD
Losartan—Asthenia—Dactinomycin—melanoma	0.000214	0.0016	CcSEcCtD
Losartan—Abdominal pain—Temozolomide—melanoma	0.000213	0.0016	CcSEcCtD
Losartan—Body temperature increased—Temozolomide—melanoma	0.000213	0.0016	CcSEcCtD
Losartan—Back pain—Docetaxel—melanoma	0.000212	0.00159	CcSEcCtD
Losartan—Muscle spasms—Docetaxel—melanoma	0.000211	0.00158	CcSEcCtD
Losartan—ACE—lymph node—melanoma	0.000207	0.00938	CbGeAlD
Losartan—Hypersensitivity—Carmustine—melanoma	0.000205	0.00154	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—melanoma	0.000204	0.00153	CcSEcCtD
Losartan—Vomiting—Bleomycin—melanoma	0.000203	0.00152	CcSEcCtD
Losartan—Anaemia—Docetaxel—melanoma	0.000203	0.00152	CcSEcCtD
Losartan—Rash—Bleomycin—melanoma	0.000201	0.00151	CcSEcCtD
Losartan—Dermatitis—Bleomycin—melanoma	0.000201	0.00151	CcSEcCtD
Losartan—Asthenia—Carmustine—melanoma	0.0002	0.0015	CcSEcCtD
Losartan—Hypersensitivity—Temozolomide—melanoma	0.000198	0.00149	CcSEcCtD
Losartan—Syncope—Docetaxel—melanoma	0.000197	0.00148	CcSEcCtD
Losartan—Leukopenia—Docetaxel—melanoma	0.000196	0.00147	CcSEcCtD
Losartan—Palpitations—Docetaxel—melanoma	0.000194	0.00146	CcSEcCtD
Losartan—Asthenia—Temozolomide—melanoma	0.000193	0.00145	CcSEcCtD
Losartan—Loss of consciousness—Docetaxel—melanoma	0.000193	0.00145	CcSEcCtD
Losartan—Cough—Docetaxel—melanoma	0.000191	0.00144	CcSEcCtD
Losartan—Diarrhoea—Carmustine—melanoma	0.000191	0.00143	CcSEcCtD
Losartan—Pruritus—Temozolomide—melanoma	0.00019	0.00143	CcSEcCtD
Losartan—Nausea—Bleomycin—melanoma	0.00019	0.00142	CcSEcCtD
Losartan—Vomiting—Dactinomycin—melanoma	0.000189	0.00142	CcSEcCtD
Losartan—Rash—Dactinomycin—melanoma	0.000188	0.00141	CcSEcCtD
Losartan—Chest pain—Docetaxel—melanoma	0.000187	0.0014	CcSEcCtD
Losartan—Myalgia—Docetaxel—melanoma	0.000187	0.0014	CcSEcCtD
Losartan—Arthralgia—Docetaxel—melanoma	0.000187	0.0014	CcSEcCtD
Losartan—Dizziness—Carmustine—melanoma	0.000184	0.00138	CcSEcCtD
Losartan—Diarrhoea—Temozolomide—melanoma	0.000184	0.00138	CcSEcCtD
Losartan—Dry mouth—Docetaxel—melanoma	0.000183	0.00137	CcSEcCtD
Losartan—ABCB1—retina—melanoma	0.000182	0.00824	CbGeAlD
Losartan—Confusional state—Docetaxel—melanoma	0.00018	0.00136	CcSEcCtD
Losartan—Anaphylactic shock—Docetaxel—melanoma	0.000179	0.00134	CcSEcCtD
Losartan—Oedema—Docetaxel—melanoma	0.000179	0.00134	CcSEcCtD
Losartan—Dizziness—Temozolomide—melanoma	0.000178	0.00134	CcSEcCtD
Losartan—Infection—Docetaxel—melanoma	0.000178	0.00134	CcSEcCtD
Losartan—Vomiting—Carmustine—melanoma	0.000177	0.00133	CcSEcCtD
Losartan—Nausea—Dactinomycin—melanoma	0.000177	0.00133	CcSEcCtD
Losartan—Shock—Docetaxel—melanoma	0.000176	0.00132	CcSEcCtD
Losartan—Rash—Carmustine—melanoma	0.000176	0.00132	CcSEcCtD
Losartan—Nervous system disorder—Docetaxel—melanoma	0.000176	0.00132	CcSEcCtD
Losartan—Dermatitis—Carmustine—melanoma	0.000175	0.00132	CcSEcCtD
Losartan—Thrombocytopenia—Docetaxel—melanoma	0.000175	0.00132	CcSEcCtD
Losartan—Tachycardia—Docetaxel—melanoma	0.000175	0.00131	CcSEcCtD
Losartan—Headache—Carmustine—melanoma	0.000175	0.00131	CcSEcCtD
Losartan—Vomiting—Temozolomide—melanoma	0.000171	0.00129	CcSEcCtD
Losartan—Anorexia—Docetaxel—melanoma	0.000171	0.00128	CcSEcCtD
Losartan—Rash—Temozolomide—melanoma	0.00017	0.00127	CcSEcCtD
Losartan—Dermatitis—Temozolomide—melanoma	0.00017	0.00127	CcSEcCtD
Losartan—Headache—Temozolomide—melanoma	0.000169	0.00127	CcSEcCtD
Losartan—Hypotension—Docetaxel—melanoma	0.000167	0.00126	CcSEcCtD
Losartan—Nausea—Carmustine—melanoma	0.000165	0.00124	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000163	0.00123	CcSEcCtD
Losartan—Insomnia—Docetaxel—melanoma	0.000162	0.00122	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—melanoma	0.000161	0.00121	CcSEcCtD
Losartan—Nausea—Temozolomide—melanoma	0.00016	0.0012	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—melanoma	0.00016	0.0012	CcSEcCtD
Losartan—Somnolence—Docetaxel—melanoma	0.000159	0.0012	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—melanoma	0.000158	0.00118	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—melanoma	0.000156	0.00117	CcSEcCtD
Losartan—Fatigue—Docetaxel—melanoma	0.000154	0.00116	CcSEcCtD
Losartan—Pain—Docetaxel—melanoma	0.000153	0.00115	CcSEcCtD
Losartan—Constipation—Docetaxel—melanoma	0.000153	0.00115	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—melanoma	0.000148	0.00111	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—melanoma	0.000146	0.0011	CcSEcCtD
Losartan—ABCB1—mammalian vulva—melanoma	0.000146	0.00659	CbGeAlD
Losartan—Abdominal pain—Docetaxel—melanoma	0.000142	0.00106	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—melanoma	0.000142	0.00106	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—melanoma	0.000132	0.000991	CcSEcCtD
Losartan—Asthenia—Docetaxel—melanoma	0.000128	0.000965	CcSEcCtD
Losartan—Pruritus—Docetaxel—melanoma	0.000127	0.000951	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—melanoma	0.000122	0.00092	CcSEcCtD
Losartan—Dizziness—Docetaxel—melanoma	0.000118	0.000889	CcSEcCtD
Losartan—Vomiting—Docetaxel—melanoma	0.000114	0.000855	CcSEcCtD
Losartan—Rash—Docetaxel—melanoma	0.000113	0.000848	CcSEcCtD
Losartan—Dermatitis—Docetaxel—melanoma	0.000113	0.000847	CcSEcCtD
Losartan—Headache—Docetaxel—melanoma	0.000112	0.000842	CcSEcCtD
Losartan—Nausea—Docetaxel—melanoma	0.000106	0.000799	CcSEcCtD
Losartan—ABCB1—head—melanoma	0.000104	0.00472	CbGeAlD
Losartan—ABCB1—lymph node—melanoma	7.3e-05	0.0033	CbGeAlD
Losartan—CYP3A4—Metabolism—PHGDH—melanoma	7.15e-06	5.04e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LUM—melanoma	7.15e-06	5.04e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—FASN—melanoma	7.14e-06	5.03e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—FASN—melanoma	7.1e-06	5.01e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PLA2G6—melanoma	7.09e-06	5e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—melanoma	7.07e-06	4.99e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—melanoma	7.05e-06	4.97e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.05e-06	4.97e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.04e-06	4.97e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTEN—melanoma	7.02e-06	4.95e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC5A5—melanoma	7.02e-06	4.95e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—melanoma	7.01e-06	4.94e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HPSE—melanoma	7.01e-06	4.94e-05	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	7.01e-06	4.94e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC5A5—melanoma	6.98e-06	4.92e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CB—melanoma	6.91e-06	4.87e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.9e-06	4.87e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP17A1—melanoma	6.89e-06	4.86e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1B—melanoma	6.89e-06	4.86e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CUBN—melanoma	6.88e-06	4.85e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—melanoma	6.85e-06	4.83e-05	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—melanoma	6.81e-06	4.81e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.81e-06	4.8e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.8e-06	4.8e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GNAQ—melanoma	6.78e-06	4.78e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CD44—melanoma	6.78e-06	4.78e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—melanoma	6.75e-06	4.76e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GNAQ—melanoma	6.74e-06	4.76e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CD44—melanoma	6.74e-06	4.76e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2—melanoma	6.74e-06	4.75e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP17A1—melanoma	6.73e-06	4.75e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CG—melanoma	6.72e-06	4.74e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	6.71e-06	4.73e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—melanoma	6.71e-06	4.73e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2—melanoma	6.66e-06	4.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SDHD—melanoma	6.64e-06	4.68e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CSPG4—melanoma	6.64e-06	4.68e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BSG—melanoma	6.64e-06	4.68e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.64e-06	4.68e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTEN—melanoma	6.62e-06	4.67e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.6e-06	4.66e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.58e-06	4.64e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—melanoma	6.57e-06	4.63e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.54e-06	4.61e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNA11—melanoma	6.51e-06	4.59e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—melanoma	6.51e-06	4.59e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1B1—melanoma	6.5e-06	4.59e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—melanoma	6.48e-06	4.57e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1B1—melanoma	6.46e-06	4.56e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CD—melanoma	6.44e-06	4.54e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPAM—melanoma	6.43e-06	4.54e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—melanoma	6.38e-06	4.5e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—FASN—melanoma	6.37e-06	4.49e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—VCAN—melanoma	6.37e-06	4.49e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—melanoma	6.36e-06	4.49e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1A—melanoma	6.36e-06	4.48e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNA11—melanoma	6.36e-06	4.48e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—melanoma	6.34e-06	4.47e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NFKB1—melanoma	6.31e-06	4.45e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP17A1—melanoma	6.29e-06	4.43e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC5A5—melanoma	6.27e-06	4.42e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.23e-06	4.39e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—FASN—melanoma	6.22e-06	4.39e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.2e-06	4.37e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—melanoma	6.19e-06	4.36e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—melanoma	6.18e-06	4.36e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	6.12e-06	4.32e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC5A5—melanoma	6.12e-06	4.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD44—melanoma	6.05e-06	4.27e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNAQ—melanoma	6.05e-06	4.27e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.03e-06	4.25e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—melanoma	5.97e-06	4.21e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNA11—melanoma	5.94e-06	4.19e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.93e-06	4.18e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNAQ—melanoma	5.91e-06	4.17e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD44—melanoma	5.91e-06	4.17e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CD—melanoma	5.9e-06	4.16e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.87e-06	4.14e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—melanoma	5.83e-06	4.11e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.82e-06	4.1e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—FASN—melanoma	5.81e-06	4.1e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1B1—melanoma	5.8e-06	4.09e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.74e-06	4.05e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—melanoma	5.73e-06	4.04e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC5A5—melanoma	5.71e-06	4.03e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.71e-06	4.02e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PRKCA—melanoma	5.69e-06	4.01e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—melanoma	5.67e-06	4e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1B1—melanoma	5.66e-06	3.99e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—melanoma	5.66e-06	3.99e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—melanoma	5.66e-06	3.99e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ERCC2—melanoma	5.64e-06	3.98e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CB—melanoma	5.62e-06	3.96e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—melanoma	5.59e-06	3.94e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—melanoma	5.57e-06	3.92e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNAQ—melanoma	5.52e-06	3.89e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD44—melanoma	5.52e-06	3.89e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PLA2G6—melanoma	5.47e-06	3.86e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—melanoma	5.42e-06	3.82e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.4e-06	3.81e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP17A1—melanoma	5.37e-06	3.79e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.36e-06	3.78e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—melanoma	5.35e-06	3.78e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—melanoma	5.35e-06	3.78e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—melanoma	5.32e-06	3.75e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.3e-06	3.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1B1—melanoma	5.29e-06	3.73e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—melanoma	5.27e-06	3.72e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	5.23e-06	3.69e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK1—melanoma	5.16e-06	3.64e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—melanoma	5.16e-06	3.64e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—melanoma	5.15e-06	3.63e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.12e-06	3.61e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—melanoma	5.1e-06	3.6e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK1—melanoma	5.1e-06	3.59e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNA11—melanoma	5.07e-06	3.58e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—FASN—melanoma	4.96e-06	3.5e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—melanoma	4.96e-06	3.49e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PRKCA—melanoma	4.93e-06	3.47e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—VCAN—melanoma	4.91e-06	3.47e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PRKCA—melanoma	4.9e-06	3.46e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ERCC2—melanoma	4.89e-06	3.45e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A5—melanoma	4.88e-06	3.44e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—melanoma	4.87e-06	3.43e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ERCC2—melanoma	4.86e-06	3.43e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—melanoma	4.85e-06	3.42e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—melanoma	4.81e-06	3.39e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—melanoma	4.78e-06	3.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNAQ—melanoma	4.72e-06	3.33e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD44—melanoma	4.72e-06	3.33e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.67e-06	3.29e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—melanoma	4.67e-06	3.29e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.62e-06	3.26e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.58e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1B1—melanoma	4.52e-06	3.19e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—melanoma	4.47e-06	3.16e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—melanoma	4.46e-06	3.14e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—melanoma	4.45e-06	3.14e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—melanoma	4.42e-06	3.12e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PRKCA—melanoma	4.4e-06	3.1e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ERCC2—melanoma	4.36e-06	3.08e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—melanoma	4.36e-06	3.07e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—melanoma	4.33e-06	3.05e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—melanoma	4.3e-06	3.03e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PRKCA—melanoma	4.29e-06	3.03e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—melanoma	4.28e-06	3.02e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ERCC2—melanoma	4.26e-06	3e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—melanoma	4.21e-06	2.97e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP17A1—melanoma	4.15e-06	2.92e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—melanoma	4.14e-06	2.92e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—melanoma	4.09e-06	2.88e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.05e-06	2.85e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—melanoma	4.05e-06	2.85e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.03e-06	2.84e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PRKCA—melanoma	4.01e-06	2.83e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.99e-06	2.81e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ERCC2—melanoma	3.98e-06	2.8e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—melanoma	3.96e-06	2.79e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—melanoma	3.92e-06	2.76e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNA11—melanoma	3.92e-06	2.76e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—melanoma	3.87e-06	2.73e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—melanoma	3.86e-06	2.72e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—melanoma	3.84e-06	2.71e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—FASN—melanoma	3.83e-06	2.7e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—melanoma	3.81e-06	2.69e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A5—melanoma	3.77e-06	2.66e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—melanoma	3.73e-06	2.63e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—melanoma	3.72e-06	2.63e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—melanoma	3.7e-06	2.61e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—melanoma	3.66e-06	2.58e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNAQ—melanoma	3.64e-06	2.57e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD44—melanoma	3.64e-06	2.57e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.61e-06	2.55e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—melanoma	3.61e-06	2.55e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1B1—melanoma	3.49e-06	2.46e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—melanoma	3.45e-06	2.43e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—melanoma	3.44e-06	2.43e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PRKCA—melanoma	3.43e-06	2.42e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—melanoma	3.42e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—melanoma	3.41e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ERCC2—melanoma	3.4e-06	2.4e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—melanoma	3.39e-06	2.39e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—melanoma	3.38e-06	2.39e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—melanoma	3.37e-06	2.38e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—melanoma	3.36e-06	2.37e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—melanoma	3.35e-06	2.36e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—melanoma	3.32e-06	2.34e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.29e-06	2.32e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—melanoma	3.25e-06	2.29e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—melanoma	3.14e-06	2.22e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—melanoma	3.14e-06	2.21e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—melanoma	3.03e-06	2.14e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—melanoma	3.03e-06	2.14e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—melanoma	2.99e-06	2.11e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—melanoma	2.96e-06	2.09e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—melanoma	2.96e-06	2.08e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—melanoma	2.95e-06	2.08e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—melanoma	2.94e-06	2.07e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—melanoma	2.93e-06	2.07e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—melanoma	2.92e-06	2.06e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—melanoma	2.91e-06	2.05e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—melanoma	2.87e-06	2.03e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.82e-06	1.99e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—melanoma	2.8e-06	1.97e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—melanoma	2.76e-06	1.95e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—melanoma	2.73e-06	1.92e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—melanoma	2.68e-06	1.89e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PRKCA—melanoma	2.64e-06	1.87e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—melanoma	2.64e-06	1.86e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ERCC2—melanoma	2.62e-06	1.85e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—melanoma	2.62e-06	1.84e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—melanoma	2.59e-06	1.83e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—melanoma	2.58e-06	1.82e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—melanoma	2.56e-06	1.81e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—melanoma	2.56e-06	1.8e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—melanoma	2.55e-06	1.8e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—melanoma	2.54e-06	1.79e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—melanoma	2.41e-06	1.7e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—melanoma	2.38e-06	1.68e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—melanoma	2.36e-06	1.66e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—melanoma	2.33e-06	1.64e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—melanoma	2.28e-06	1.61e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—melanoma	2.23e-06	1.57e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—melanoma	2.08e-06	1.47e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—melanoma	2.08e-06	1.47e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—melanoma	2.07e-06	1.46e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—melanoma	2.06e-06	1.45e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—melanoma	2.04e-06	1.44e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—melanoma	2e-06	1.41e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—melanoma	1.82e-06	1.28e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—melanoma	1.8e-06	1.27e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—melanoma	1.8e-06	1.27e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—melanoma	1.79e-06	1.26e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—melanoma	1.78e-06	1.25e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—melanoma	1.7e-06	1.2e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—melanoma	1.61e-06	1.13e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—melanoma	1.59e-06	1.12e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—melanoma	1.57e-06	1.11e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—melanoma	1.57e-06	1.11e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—melanoma	1.47e-06	1.04e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—melanoma	1.47e-06	1.03e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—melanoma	1.46e-06	1.03e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—melanoma	1.37e-06	9.67e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—melanoma	1.31e-06	9.27e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—melanoma	1.28e-06	9.05e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—melanoma	1.25e-06	8.84e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—melanoma	1.2e-06	8.45e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—melanoma	1.02e-06	7.22e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—melanoma	9.68e-07	6.82e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—melanoma	7.91e-07	5.57e-06	CbGpPWpGaD
